Transaction in Own Shares
Rhea-AI Summary
Shell plc (NYSE:SHEL) purchased 1,316,305 shares for cancellation on 23 April 2026 across LSE, Chi-X, BATS, XAMS, CBOE DXE and TQEX. Transactions show venue-level VWAPs of ~33.11 GBP and ~38.23 EUR. Purchases were executed under the buyback programme announced 05 February 2026, managed independently by Morgan Stanley & Co. International Plc and conducted within prescribed UK MAR/EU MAR parameters.
Positive
- 1,316,305 shares purchased for cancellation on 23 April 2026
- Buyback executed across six trading venues, showing diversified execution
- Trades effected under independent management by Morgan Stanley within preset parameters
Negative
- Aggregate cash consideration of trades approximately £21.77m and €25.19m (venue VWAPs), reducing liquidity
- Buyback is ongoing under programme limits; further purchases may continue through 01 May 2026
Key Figures
Market Reality Check
Peers on Argus
SHEL was up 0.94% while large peers were mixed: CVX -0.51%, XOM +0.09%, TTE -0.03%, BP -0.47%, PBR -0.19%, indicating a stock-specific move around the buyback activity.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Apr 22 | Share buy-back | Positive | +1.0% | Disclosure of 1,247,760 shares repurchased and cancelled under buy-back. |
| Apr 21 | Share buy-back | Positive | +0.8% | Update on 1,309,220 shares bought for cancellation across venues. |
| Apr 20 | Share buy-back | Positive | +0.2% | Report of 1,165,886 shares cancelled under ongoing programme. |
| Apr 17 | Share buy-back | Positive | -4.0% | Larger 2,741,165-share cancellation coincided with a -4.03% move. |
| Apr 16 | Share buy-back | Positive | +1.9% | 1,620,931 shares repurchased with detailed GBP/EUR venue VWAPs. |
Recent buy-back disclosures often coincided with modest positive moves, with one notable negative reaction.
Over the last week, Shell has reported daily buy-back activity, cancelling between 1.16M and 2.74M shares per day across European venues. These transactions all relate to the programme announced on 05 Feb 2026, running to 01 May 2026 and executed independently by Morgan Stanley under UK MAR/EU MAR frameworks. Price reactions have generally been mildly positive, with one -4.03% down day, suggesting the market has mostly absorbed these repurchases without large dislocations.
Market Pulse Summary
This announcement details another day of buy-back activity, with hundreds of thousands of shares repurchased across LSE, Chi-X, BATS, XAMS, CBOE DXE and TQEX under the programme running from 05 February 2026 to 01 May 2026. It continues a pattern of regular cancellations disclosed in recent days. Investors may track cumulative volumes, venue-level VWAPs in GBP and EUR, and the stock’s position relative to the 76.67 200-day MA and 94.9 52-week high to gauge how the market absorbs this capital return.
Key Terms
EU MAR regulatory
UK MAR regulatory
off-market buyback contract financial
trading venue technical
on-market limb financial
AI-generated analysis. Not financial advice.
Transaction in Own Shares
23 April 2026
• • • • • • • • • • • • • • • •
Shell plc (the ‘Company’) announces that on 23 April 2026 it purchased the following number of Shares for cancellation.
Aggregated information on Shares purchased according to trading venue:
| Date of Purchase | Number of Shares purchased | Highest price paid | Lowest price paid | Volume weighted average price paid per share | Venue | Currency |
| 23/04/2026 | 421,916 | 33.3250 | 32.9900 | 33.1161 | LSE | GBP |
| 23/04/2026 | 175,330 | 33.3250 | 32.9950 | 33.1113 | Chi-X (CXE) | GBP |
| 23/04/2026 | 60,271 | 33.2900 | 32.9950 | 33.1118 | BATS (BXE) | GBP |
| 23/04/2026 | 384,570 | 38.4600 | 38.0550 | 38.2323 | XAMS | EUR |
| 23/04/2026 | 234,311 | 38.4650 | 38.0550 | 38.2315 | CBOE DXE | EUR |
| 23/04/2026 | 39,907 | 38.4350 | 38.0550 | 38.2238 | TQEX | EUR |
These share purchases form part of the on- and off-market limbs of the Company's existing share buy-back programme previously announced on 05 February 2026.
In respect of this programme, Morgan Stanley & Co. International Plc will make trading decisions in relation to the securities independently of the Company for a period from 05 February 2026 up to and including 01 May 2026.
The on-market limb will be effected within certain pre-set parameters and in accordance with the Company’s general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company’s general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (“EU MAR”) and EU MAR as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (“UK MAR”) and the Commission Delegated Regulation (EU) 2016/1052 (the “EU MAR Delegated Regulation”) and the EU MAR Delegated Regulation as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.
In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Morgan Stanley & Co. International Plc on behalf of the Company as a part of the buy-back programme is detailed below.
Enquiries
Media: International +44 (0) 207 934 5550; U.S. and Canada: https://www.shell.us/about-us/news-and-insights/media/submit-an-inquiry.html
Attachment